188 related articles for article (PubMed ID: 26966889)
1. New developments in flavivirus drug discovery.
Kok WM
Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets for flavivirus drug discovery.
Sampath A; Padmanabhan R
Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
[TBL] [Abstract][Full Text] [Related]
3. Rodent models for the study of therapy against flavivirus infections.
Charlier N; Leyssen P; De Clercq E; Neyts J
Antiviral Res; 2004 Aug; 63(2):67-77. PubMed ID: 15321702
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to flavivirus drug discovery.
Botting C; Kuhn RJ
Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
[TBL] [Abstract][Full Text] [Related]
5. Present perspectives on flaviviral chemotherapy.
Ghosh D; Basu A
Drug Discov Today; 2008 Jul; 13(13-14):619-24. PubMed ID: 18598919
[TBL] [Abstract][Full Text] [Related]
6. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in flavivirus antiviral drug discovery and vaccine development.
Ray D; Shi PY
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
[TBL] [Abstract][Full Text] [Related]
8. Focus on flaviviruses: current and future drug targets.
Geiss BJ; Stahla H; Hannah AM; Gari AM; Keenan SM
Future Med Chem; 2009 May; 1(2):327-44. PubMed ID: 20165556
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
10. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.
Felicetti T; Manfroni G; Cecchetti V; Cannalire R
ChemMedChem; 2020 Dec; 15(24):2391-2419. PubMed ID: 32961008
[TBL] [Abstract][Full Text] [Related]
11. [New approaches to the treatment of the flavivirus infections].
Morozova OV; Isaeva EI; Viazov SO
Vopr Virusol; 2015; 60(6):5-9. PubMed ID: 27024909
[TBL] [Abstract][Full Text] [Related]
12. Review of Phytochemical Compounds as Antiviral Agents Against Arboviruses from the Genera Flavivirus and Alphavirus.
Sardari S; Rafieian-Kopaei M; Malekmohammad K; Sewell RDE
Curr Drug Discov Technol; 2020; 17(4):484-497. PubMed ID: 31969106
[TBL] [Abstract][Full Text] [Related]
13. Cellular Targets for the Treatment of Flavivirus Infections.
Zakaria MK; Carletti T; Marcello A
Front Cell Infect Microbiol; 2018; 8():398. PubMed ID: 30483483
[TBL] [Abstract][Full Text] [Related]
14. The flavivirus capsid protein: Structure, function and perspectives towards drug design.
Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC
Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882
[TBL] [Abstract][Full Text] [Related]
15. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
Eyer L; Nencka R; de Clercq E; Seley-Radtke K; Růžek D
Antivir Chem Chemother; 2018; 26():2040206618761299. PubMed ID: 29534608
[TBL] [Abstract][Full Text] [Related]
17. Finding new medicines for flaviviral targets.
Keller TH; Chen YL; Knox JE; Lim SP; Ma NL; Patel SJ; Sampath A; Wang QY; Yin Z; Vasudevan SG
Novartis Found Symp; 2006; 277():102-14; discussion 114-9, 251-3. PubMed ID: 17319157
[TBL] [Abstract][Full Text] [Related]
18. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
[TBL] [Abstract][Full Text] [Related]
19. Development of novel antivirals against flaviviruses.
Patkar CG; Kuhn RJ
Novartis Found Symp; 2006; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153
[TBL] [Abstract][Full Text] [Related]
20. The importance of viral and cellular factors on flavivirus entry.
Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
